

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | phospholipid scrambling (GO:0017121) | 6.96542833 |
| 2 | definitive hemopoiesis (GO:0060216) | 5.68977366 |
| 3 | detection of bacterium (GO:0016045) | 5.53449355 |
| 4 | detection of other organism (GO:0098543) | 5.46157824 |
| 5 | motile cilium assembly (GO:0044458) | 4.91971611 |
| 6 | endothelium development (GO:0003158) | 4.77799859 |
| 7 | lymph vessel development (GO:0001945) | 4.74648927 |
| 8 | muscle organ morphogenesis (GO:0048644) | 4.60750947 |
| 9 | vascular endothelial growth factor signaling pathway (GO:0038084) | 4.42892734 |
| 10 | iron ion import (GO:0097286) | 4.27596727 |
| 11 | surfactant homeostasis (GO:0043129) | 4.21139645 |
| 12 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.09135365 |
| 13 | platelet dense granule organization (GO:0060155) | 4.08616342 |
| 14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.97913588 |
| 15 | neutrophil activation involved in immune response (GO:0002283) | 3.88926721 |
| 16 | regulation of antigen processing and presentation (GO:0002577) | 3.84437546 |
| 17 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.84265228 |
| 18 | detection of molecule of bacterial origin (GO:0032490) | 3.84011420 |
| 19 | response to peptidoglycan (GO:0032494) | 3.81501550 |
| 20 | regulation of cellular extravasation (GO:0002691) | 3.76709710 |
| 21 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.74349319 |
| 22 | axonemal dynein complex assembly (GO:0070286) | 3.71640017 |
| 23 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.66796246 |
| 24 | positive regulation of antigen processing and presentation (GO:0002579) | 3.60848809 |
| 25 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.59771481 |
| 26 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.58584413 |
| 27 | detection of external biotic stimulus (GO:0098581) | 3.56627300 |
| 28 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.52581464 |
| 29 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.52581464 |
| 30 | negative regulation of stress fiber assembly (GO:0051497) | 3.41740539 |
| 31 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.41578647 |
| 32 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.39868770 |
| 33 | detection of biotic stimulus (GO:0009595) | 3.38457939 |
| 34 | oligosaccharide catabolic process (GO:0009313) | 3.34977092 |
| 35 | protein localization to endosome (GO:0036010) | 3.34041610 |
| 36 | embryonic process involved in female pregnancy (GO:0060136) | 3.33464797 |
| 37 | sprouting angiogenesis (GO:0002040) | 3.27190876 |
| 38 | chemical homeostasis within a tissue (GO:0048875) | 3.27034603 |
| 39 | response to thyroid hormone (GO:0097066) | 3.23529136 |
| 40 | macrophage activation involved in immune response (GO:0002281) | 3.19946462 |
| 41 | germ cell migration (GO:0008354) | 3.14734875 |
| 42 | glycosphingolipid catabolic process (GO:0046479) | 3.14624326 |
| 43 | positive regulation of vasculogenesis (GO:2001214) | 3.12629696 |
| 44 | positive regulation of respiratory burst (GO:0060267) | 3.10400008 |
| 45 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.05316728 |
| 46 | NIK/NF-kappaB signaling (GO:0038061) | 3.05241097 |
| 47 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 3.03770036 |
| 48 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.01427287 |
| 49 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.01089456 |
| 50 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.97065028 |
| 51 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.97065028 |
| 52 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.97065028 |
| 53 | modulation by symbiont of host immune response (GO:0052553) | 2.97065028 |
| 54 | positive regulation by symbiont of host defense response (GO:0052509) | 2.97065028 |
| 55 | modulation by symbiont of host defense response (GO:0052031) | 2.97065028 |
| 56 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.96411249 |
| 57 | negative regulation of interleukin-12 production (GO:0032695) | 2.95332940 |
| 58 | cellular response to arsenic-containing substance (GO:0071243) | 2.88674107 |
| 59 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.87209029 |
| 60 | T-helper cell differentiation (GO:0042093) | 2.85447495 |
| 61 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.85447495 |
| 62 | glycolipid catabolic process (GO:0019377) | 2.84964390 |
| 63 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.83803998 |
| 64 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.82905251 |
| 65 | blood vessel maturation (GO:0001955) | 2.81295969 |
| 66 | positive regulation of T cell migration (GO:2000406) | 2.80667959 |
| 67 | regulation of vasculogenesis (GO:2001212) | 2.80477555 |
| 68 | regulation of membrane lipid distribution (GO:0097035) | 2.80294640 |
| 69 | cellular response to ethanol (GO:0071361) | 2.80118756 |
| 70 | monocyte chemotaxis (GO:0002548) | 2.77974774 |
| 71 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.74867907 |
| 72 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.74495536 |
| 73 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.72604580 |
| 74 | regulation of necroptotic process (GO:0060544) | 2.71279284 |
| 75 | regulation of interferon-alpha production (GO:0032647) | 2.70801290 |
| 76 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.69064540 |
| 77 | negative regulation of actin filament bundle assembly (GO:0032232) | 2.68440067 |
| 78 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.67746708 |
| 79 | establishment of endothelial barrier (GO:0061028) | 2.66946609 |
| 80 | T-helper 1 type immune response (GO:0042088) | 2.65723877 |
| 81 | regulation of chemokine biosynthetic process (GO:0045073) | 2.65689605 |
| 82 | cell wall macromolecule metabolic process (GO:0044036) | 2.65422715 |
| 83 | cell wall macromolecule catabolic process (GO:0016998) | 2.65422715 |
| 84 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.65167917 |
| 85 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.64243595 |
| 86 | patterning of blood vessels (GO:0001569) | 2.64066218 |
| 87 | regulation of mononuclear cell migration (GO:0071675) | 2.62484647 |
| 88 | phagocytosis, engulfment (GO:0006911) | 2.62446622 |
| 89 | positive regulation of interferon-alpha production (GO:0032727) | 2.62276702 |
| 90 | cytokine biosynthetic process (GO:0042089) | 2.60853655 |
| 91 | germinal center formation (GO:0002467) | 2.59909335 |
| 92 | regulation of macrophage chemotaxis (GO:0010758) | 2.59299328 |
| 93 | secretory granule organization (GO:0033363) | 2.58715464 |
| 94 | endothelial tube morphogenesis (GO:0061154) | 2.57707304 |
| 95 | morphogenesis of an endothelium (GO:0003159) | 2.57707304 |
| 96 | artery smooth muscle contraction (GO:0014824) | 2.57021407 |
| 97 | megakaryocyte development (GO:0035855) | 2.54856054 |
| 98 | low-density lipoprotein particle clearance (GO:0034383) | 2.54163493 |
| 99 | immunoglobulin mediated immune response (GO:0016064) | 2.53791022 |
| 100 | defense response to protozoan (GO:0042832) | 2.53307682 |
| 101 | response to laminar fluid shear stress (GO:0034616) | 2.52837520 |
| 102 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.52037020 |
| 103 | positive regulation of macrophage cytokine production (GO:0060907) | 2.51484179 |
| 104 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.51373736 |
| 105 | positive regulation of lymphocyte migration (GO:2000403) | 2.50669998 |
| 106 | positive regulation of type 2 immune response (GO:0002830) | 2.50601396 |
| 107 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.50100303 |
| 108 | radial glial cell differentiation (GO:0060019) | 2.48935023 |
| 109 | regulation of T cell migration (GO:2000404) | 2.48216833 |
| 110 | regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947) | 2.48072858 |
| 111 | response to muramyl dipeptide (GO:0032495) | 2.47418453 |
| 112 | histamine secretion (GO:0001821) | 2.47133452 |
| 113 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.46794066 |
| 114 | negative regulation of lipid storage (GO:0010888) | 2.46226414 |
| 115 | lymphangiogenesis (GO:0001946) | 2.45542533 |
| 116 | sodium-independent organic anion transport (GO:0043252) | 2.45517993 |
| 117 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.45187137 |
| 118 | response to protozoan (GO:0001562) | 2.45099942 |
| 119 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.44795217 |
| 120 | COPI coating of Golgi vesicle (GO:0048205) | 2.44201168 |
| 121 | Golgi transport vesicle coating (GO:0048200) | 2.44201168 |
| 122 | toxin transport (GO:1901998) | 2.44037647 |
| 123 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.43575647 |
| 124 | cytokine secretion (GO:0050663) | 2.43415160 |
| 125 | regulation of chronic inflammatory response (GO:0002676) | 2.41750988 |
| 126 | response to interferon-alpha (GO:0035455) | 2.41560144 |
| 127 | mast cell activation (GO:0045576) | 2.41180472 |
| 128 | tonic smooth muscle contraction (GO:0014820) | 2.40700550 |
| 129 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.40604433 |
| 130 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.40548058 |
| 131 | regulation of germinal center formation (GO:0002634) | 2.39059969 |
| 132 | ovulation from ovarian follicle (GO:0001542) | 2.38661646 |
| 133 | negative regulation of interleukin-17 production (GO:0032700) | 2.38525143 |
| 134 | macrophage activation (GO:0042116) | 2.37377635 |
| 135 | necroptotic process (GO:0070266) | 2.37224746 |
| 136 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 2.37004683 |
| 137 | phagocytosis, recognition (GO:0006910) | 2.36039341 |
| 138 | Notch receptor processing (GO:0007220) | 2.35890097 |
| 139 | plasma membrane fusion (GO:0045026) | 2.35696378 |
| 140 | sphingoid metabolic process (GO:0046519) | 2.35526154 |
| 141 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 2.35463198 |
| 142 | gas transport (GO:0015669) | 2.34640939 |
| 143 | response to type I interferon (GO:0034340) | 2.34382234 |
| 144 | endothelial cell differentiation (GO:0045446) | 2.34318860 |
| 145 | sperm motility (GO:0030317) | 2.33755055 |
| 146 | embryonic camera-type eye morphogenesis (GO:0048596) | 2.33218431 |
| 147 | regulation of response to interferon-gamma (GO:0060330) | 2.32752060 |
| 148 | positive regulation of p38MAPK cascade (GO:1900745) | 2.31691659 |
| 149 | alpha-linolenic acid metabolic process (GO:0036109) | 2.31675568 |
| 150 | endosome to melanosome transport (GO:0035646) | 2.31542681 |
| 151 | endosome to pigment granule transport (GO:0043485) | 2.31542681 |
| 152 | negative regulation of endothelial cell apoptotic process (GO:2000352) | 2.30994580 |
| 153 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.30311287 |
| 154 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.30311287 |
| 155 | nuclear pore complex assembly (GO:0051292) | 2.30087502 |
| 156 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.29606531 |
| 157 | cytokine metabolic process (GO:0042107) | 2.29494773 |
| 158 | Notch signaling involved in heart development (GO:0061314) | 2.29217556 |
| 159 | ceramide catabolic process (GO:0046514) | 2.29123053 |
| 160 | N-acetylneuraminate metabolic process (GO:0006054) | 2.28906188 |
| 161 | granulocyte activation (GO:0036230) | 2.28834154 |
| 162 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.28771904 |
| 163 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.28771904 |
| 164 | T cell differentiation involved in immune response (GO:0002292) | 2.28771904 |
| 165 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.28317410 |
| 166 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.28033933 |
| 167 | cellular extravasation (GO:0045123) | 2.27307442 |
| 168 | regulation of RIG-I signaling pathway (GO:0039535) | 2.26860925 |
| 169 | import into cell (GO:0098657) | 2.26171127 |
| 170 | positive regulation of interleukin-6 production (GO:0032755) | 2.25956222 |
| 171 | regulation of mast cell degranulation (GO:0043304) | 2.25433353 |
| 172 | regulation of necrotic cell death (GO:0010939) | 2.25161298 |
| 173 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.25030698 |
| 174 | regulation of early endosome to late endosome transport (GO:2000641) | 2.24933632 |
| 175 | cell adhesion mediated by integrin (GO:0033627) | 2.24229720 |
| 176 | hypotonic response (GO:0006971) | 2.23952805 |
| 177 | positive regulation of leukocyte degranulation (GO:0043302) | 2.21550714 |
| 178 | type I interferon signaling pathway (GO:0060337) | 2.21549859 |
| 179 | cellular response to type I interferon (GO:0071357) | 2.21549859 |
| 180 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.20757687 |
| 181 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.20661984 |
| 182 | regulation of podosome assembly (GO:0071801) | 2.20343581 |
| 183 | membrane raft organization (GO:0031579) | 2.20321474 |
| 184 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.19650212 |
| 185 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.18809205 |
| 186 | cellular response to interferon-alpha (GO:0035457) | 2.18422337 |
| 187 | regulation of macrophage cytokine production (GO:0010935) | 2.18328049 |
| 188 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.17827535 |
| 189 | hepatocyte apoptotic process (GO:0097284) | 2.17677936 |
| 190 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.17665008 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SCL_19346495_ChIP-Seq_HPC-7_Human | 4.13756430 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.77079153 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.73674327 |
| 4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.67604680 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.57966963 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.56237462 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.52095449 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.50523185 |
| 9 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 3.27810987 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.97167589 |
| 11 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.70728595 |
| 12 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.56334325 |
| 13 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.50833075 |
| 14 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.45566754 |
| 15 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.42619879 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.25192936 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.17350669 |
| 18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.12284298 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.11677621 |
| 20 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.11061682 |
| 21 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.10390568 |
| 22 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.04281332 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.98298748 |
| 24 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.96576767 |
| 25 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.91497991 |
| 26 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.88915494 |
| 27 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.83769631 |
| 28 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.80321506 |
| 29 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.79019827 |
| 30 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.77632768 |
| 31 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.75647617 |
| 32 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.75383331 |
| 33 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.74194154 |
| 34 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.73829716 |
| 35 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.70397834 |
| 36 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.65907365 |
| 37 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62232495 |
| 38 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.61689545 |
| 39 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.60723581 |
| 40 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.59538516 |
| 41 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.59383867 |
| 42 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.56752550 |
| 43 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.56028895 |
| 44 | CJUN_26792858_Chip-Seq_BT549_Human | 1.53657094 |
| 45 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.49862253 |
| 46 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.49654174 |
| 47 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.48091994 |
| 48 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.46811838 |
| 49 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.46811838 |
| 50 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.46222860 |
| 51 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.45728818 |
| 52 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.45388344 |
| 53 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.44005614 |
| 54 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.43407388 |
| 55 | GATA1_22025678_ChIP-Seq_K562_Human | 1.41826802 |
| 56 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.41546656 |
| 57 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.41246294 |
| 58 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.41178996 |
| 59 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.41120014 |
| 60 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.39052749 |
| 61 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.38599384 |
| 62 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.37884780 |
| 63 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.37670387 |
| 64 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.35853274 |
| 65 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.33793866 |
| 66 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.33792052 |
| 67 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.29264271 |
| 68 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.28447439 |
| 69 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.27807561 |
| 70 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.26637833 |
| 71 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26471172 |
| 72 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.25003458 |
| 73 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.23093498 |
| 74 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.22542330 |
| 75 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19637686 |
| 76 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.19594858 |
| 77 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.19094718 |
| 78 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.19003415 |
| 79 | MYB_26560356_Chip-Seq_TH2_Human | 1.18674548 |
| 80 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.16913719 |
| 81 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.16627288 |
| 82 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.15870309 |
| 83 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.14967871 |
| 84 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.14909858 |
| 85 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.14823874 |
| 86 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.14753439 |
| 87 | RXR_22108803_ChIP-Seq_LS180_Human | 1.14221747 |
| 88 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.13338071 |
| 89 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.10973742 |
| 90 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.10527835 |
| 91 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.10517648 |
| 92 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.07740257 |
| 93 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.07314403 |
| 94 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07312851 |
| 95 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.07167185 |
| 96 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.06794094 |
| 97 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.06317099 |
| 98 | * MAF_26560356_Chip-Seq_TH1_Human | 1.05815016 |
| 99 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04698300 |
| 100 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.04539519 |
| 101 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02991553 |
| 102 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02936865 |
| 103 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.02424731 |
| 104 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.02424731 |
| 105 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.01900116 |
| 106 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.01749141 |
| 107 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.00305739 |
| 108 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99760227 |
| 109 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.99331168 |
| 110 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.98547424 |
| 111 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.98410887 |
| 112 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.98184920 |
| 113 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.98154391 |
| 114 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.98154391 |
| 115 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.98025649 |
| 116 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.97875342 |
| 117 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.96484249 |
| 118 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.96406233 |
| 119 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.95871466 |
| 120 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.95744339 |
| 121 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.95261039 |
| 122 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.93669397 |
| 123 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.92245532 |
| 124 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.91707794 |
| 125 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.91448340 |
| 126 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.91080362 |
| 127 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.90865044 |
| 128 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.90295830 |
| 129 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89953375 |
| 130 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.89539977 |
| 131 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.85991834 |
| 132 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85490865 |
| 133 | * MYB_26560356_Chip-Seq_TH1_Human | 0.85437023 |
| 134 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84313592 |
| 135 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.83773439 |
| 136 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.83529158 |
| 137 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.83362157 |
| 138 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.83311742 |
| 139 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.81920946 |
| 140 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.81332767 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009278_abnormal_bone_marrow | 3.92570782 |
| 2 | MP0004147_increased_porphyrin_level | 3.49198319 |
| 3 | MP0005167_abnormal_blood-brain_barrier | 3.34168518 |
| 4 | MP0001879_abnormal_lymphatic_vessel | 3.10525030 |
| 5 | MP0009379_abnormal_foot_pigmentation | 3.08302383 |
| 6 | MP0003303_peritoneal_inflammation | 3.06624453 |
| 7 | MP0001873_stomach_inflammation | 3.03357044 |
| 8 | MP0003656_abnormal_erythrocyte_physiolo | 2.97177076 |
| 9 | MP0003950_abnormal_plasma_membrane | 2.96608739 |
| 10 | MP0003724_increased_susceptibility_to | 2.92810998 |
| 11 | MP0010368_abnormal_lymphatic_system | 2.84002007 |
| 12 | MP0001545_abnormal_hematopoietic_system | 2.62767945 |
| 13 | MP0005397_hematopoietic_system_phenotyp | 2.62767945 |
| 14 | MP0002009_preneoplasia | 2.57181348 |
| 15 | MP0005451_abnormal_body_composition | 2.39334561 |
| 16 | MP0005058_abnormal_lysosome_morphology | 2.29432912 |
| 17 | MP0001835_abnormal_antigen_presentation | 2.23355958 |
| 18 | MP0003828_pulmonary_edema | 2.10443742 |
| 19 | MP0001188_hyperpigmentation | 2.06963321 |
| 20 | MP0008438_abnormal_cutaneous_collagen | 1.98604382 |
| 21 | MP0009840_abnormal_foam_cell | 1.98333919 |
| 22 | MP0005410_abnormal_fertilization | 1.98101972 |
| 23 | MP0003941_abnormal_skin_development | 1.97252127 |
| 24 | MP0010234_abnormal_vibrissa_follicle | 1.93511226 |
| 25 | MP0003453_abnormal_keratinocyte_physiol | 1.93141276 |
| 26 | MP0008004_abnormal_stomach_pH | 1.90837780 |
| 27 | MP0004808_abnormal_hematopoietic_stem | 1.89668099 |
| 28 | MP0003191_abnormal_cellular_cholesterol | 1.87790695 |
| 29 | MP0003705_abnormal_hypodermis_morpholog | 1.81024100 |
| 30 | MP0002419_abnormal_innate_immunity | 1.71388219 |
| 31 | MP0010352_gastrointestinal_tract_polyps | 1.71270421 |
| 32 | MP0009697_abnormal_copulation | 1.69811637 |
| 33 | MP0009785_altered_susceptibility_to | 1.67674641 |
| 34 | MP0002148_abnormal_hypersensitivity_rea | 1.66887886 |
| 35 | MP0008995_early_reproductive_senescence | 1.64500422 |
| 36 | MP0002166_altered_tumor_susceptibility | 1.64347411 |
| 37 | MP0008260_abnormal_autophagy | 1.63133593 |
| 38 | MP0002332_abnormal_exercise_endurance | 1.61148758 |
| 39 | MP0005275_abnormal_skin_tensile | 1.61053339 |
| 40 | MP0004484_altered_response_of | 1.60656322 |
| 41 | MP0005464_abnormal_platelet_physiology | 1.60101555 |
| 42 | MP0001853_heart_inflammation | 1.59844044 |
| 43 | MP0003300_gastrointestinal_ulcer | 1.58201805 |
| 44 | MP0003943_abnormal_hepatobiliary_system | 1.56395433 |
| 45 | MP0004510_myositis | 1.53453789 |
| 46 | MP0002452_abnormal_antigen_presenting | 1.52318435 |
| 47 | MP0005670_abnormal_white_adipose | 1.51285139 |
| 48 | MP0005084_abnormal_gallbladder_morpholo | 1.51093629 |
| 49 | MP0003075_altered_response_to | 1.48313025 |
| 50 | MP0002006_tumorigenesis | 1.48072633 |
| 51 | MP0002796_impaired_skin_barrier | 1.47311428 |
| 52 | MP0005171_absent_coat_pigmentation | 1.46691368 |
| 53 | MP0006054_spinal_hemorrhage | 1.46302436 |
| 54 | MP0004947_skin_inflammation | 1.45876481 |
| 55 | MP0002139_abnormal_hepatobiliary_system | 1.45860939 |
| 56 | MP0005025_abnormal_response_to | 1.44558173 |
| 57 | MP0003279_aneurysm | 1.43501036 |
| 58 | MP0005409_darkened_coat_color | 1.43114878 |
| 59 | MP0003436_decreased_susceptibility_to | 1.41470953 |
| 60 | MP0005671_abnormal_response_to | 1.40794388 |
| 61 | MP0000858_altered_metastatic_potential | 1.40657802 |
| 62 | MP0003566_abnormal_cell_adhesion | 1.40100032 |
| 63 | MP0000465_gastrointestinal_hemorrhage | 1.39780036 |
| 64 | MP0005387_immune_system_phenotype | 1.39707572 |
| 65 | MP0001790_abnormal_immune_system | 1.39707572 |
| 66 | MP0004272_abnormal_basement_membrane | 1.33783656 |
| 67 | MP0002396_abnormal_hematopoietic_system | 1.31212715 |
| 68 | MP0004782_abnormal_surfactant_physiolog | 1.31043934 |
| 69 | MP0000372_irregular_coat_pigmentation | 1.30865669 |
| 70 | MP0008057_abnormal_DNA_replication | 1.30814795 |
| 71 | MP0005000_abnormal_immune_tolerance | 1.30154978 |
| 72 | MP0002723_abnormal_immune_serum | 1.27010476 |
| 73 | MP0005165_increased_susceptibility_to | 1.26645816 |
| 74 | MP0001819_abnormal_immune_cell | 1.24510080 |
| 75 | MP0002420_abnormal_adaptive_immunity | 1.24475512 |
| 76 | MP0004381_abnormal_hair_follicle | 1.24400595 |
| 77 | MP0001851_eye_inflammation | 1.23879861 |
| 78 | MP0001800_abnormal_humoral_immune | 1.22309591 |
| 79 | MP0000015_abnormal_ear_pigmentation | 1.20067624 |
| 80 | MP0005083_abnormal_biliary_tract | 1.19033046 |
| 81 | MP0005174_abnormal_tail_pigmentation | 1.18729198 |
| 82 | MP0000249_abnormal_blood_vessel | 1.17657714 |
| 83 | MP0002405_respiratory_system_inflammati | 1.15712566 |
| 84 | MP0009764_decreased_sensitivity_to | 1.15070301 |
| 85 | MP0005501_abnormal_skin_physiology | 1.14294287 |
| 86 | MP0003690_abnormal_glial_cell | 1.13980235 |
| 87 | MP0010155_abnormal_intestine_physiology | 1.13451415 |
| 88 | MP0003183_abnormal_peptide_metabolism | 1.13137165 |
| 89 | MP0000767_abnormal_smooth_muscle | 1.12707563 |
| 90 | MP0004883_abnormal_blood_vessel | 1.11378601 |
| 91 | MP0005310_abnormal_salivary_gland | 1.11377108 |
| 92 | MP0003091_abnormal_cell_migration | 1.11203845 |
| 93 | MP0005076_abnormal_cell_differentiation | 1.09998037 |
| 94 | MP0003172_abnormal_lysosome_physiology | 1.09291434 |
| 95 | MP0005023_abnormal_wound_healing | 1.09045321 |
| 96 | MP0003806_abnormal_nucleotide_metabolis | 1.08545140 |
| 97 | MP0005075_abnormal_melanosome_morpholog | 1.05013234 |
| 98 | MP0000343_altered_response_to | 1.04748990 |
| 99 | MP0000685_abnormal_immune_system | 1.02167156 |
| 100 | MP0002254_reproductive_system_inflammat | 0.95948047 |
| 101 | MP0000604_amyloidosis | 0.95544449 |
| 102 | MP0006082_CNS_inflammation | 0.92587498 |
| 103 | MP0005666_abnormal_adipose_tissue | 0.92435526 |
| 104 | MP0009763_increased_sensitivity_to | 0.92240336 |
| 105 | MP0002098_abnormal_vibrissa_morphology | 0.92149565 |
| 106 | MP0001845_abnormal_inflammatory_respons | 0.91998018 |
| 107 | MP0001533_abnormal_skeleton_physiology | 0.89561911 |
| 108 | MP0002928_abnormal_bile_duct | 0.89173213 |
| 109 | MP0001216_abnormal_epidermal_layer | 0.88075840 |
| 110 | MP0001191_abnormal_skin_condition | 0.86084061 |
| 111 | MP0004233_abnormal_muscle_weight | 0.85743355 |
| 112 | MP0004264_abnormal_extraembryonic_tissu | 0.85542333 |
| 113 | MP0005595_abnormal_vascular_smooth | 0.85491609 |
| 114 | MP0006138_congestive_heart_failure | 0.84654204 |
| 115 | MP0002998_abnormal_bone_remodeling | 0.83999577 |
| 116 | MP0002398_abnormal_bone_marrow | 0.83899513 |
| 117 | MP0010678_abnormal_skin_adnexa | 0.83627833 |
| 118 | MP0001958_emphysema | 0.83258868 |
| 119 | MP0009115_abnormal_fat_cell | 0.81654414 |
| 120 | MP0005166_decreased_susceptibility_to | 0.81584490 |
| 121 | MP0010630_abnormal_cardiac_muscle | 0.81487241 |
| 122 | MP0004185_abnormal_adipocyte_glucose | 0.81431998 |
| 123 | MP0002128_abnormal_blood_circulation | 0.81221618 |
| 124 | MP0008007_abnormal_cellular_replicative | 0.80767897 |
| 125 | MP0002132_abnormal_respiratory_system | 0.78381834 |
| 126 | MP0000609_abnormal_liver_physiology | 0.78277122 |
| 127 | MP0005164_abnormal_response_to | 0.78215577 |
| 128 | MP0003448_altered_tumor_morphology | 0.77494287 |
| 129 | MP0000716_abnormal_immune_system | 0.77450326 |
| 130 | MP0002095_abnormal_skin_pigmentation | 0.77299110 |
| 131 | MP0002060_abnormal_skin_morphology | 0.76440201 |
| 132 | MP0003795_abnormal_bone_structure | 0.76024202 |
| 133 | MP0002295_abnormal_pulmonary_circulatio | 0.74628835 |
| 134 | MP0002136_abnormal_kidney_physiology | 0.74061213 |
| 135 | MP0002877_abnormal_melanocyte_morpholog | 0.72372548 |
| 136 | MP0000689_abnormal_spleen_morphology | 0.72058623 |
| 137 | MP0001919_abnormal_reproductive_system | 0.71469562 |
| 138 | MP0008469_abnormal_protein_level | 0.70906495 |
| 139 | MP0002429_abnormal_blood_cell | 0.70534715 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 6.67642140 |
| 2 | Absent/shortened dynein arms (HP:0200106) | 6.67642140 |
| 3 | Abnormality of the nasal mucosa (HP:0000433) | 4.85287424 |
| 4 | Nasal polyposis (HP:0100582) | 4.62212057 |
| 5 | Recurrent abscess formation (HP:0002722) | 4.37061891 |
| 6 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.17681423 |
| 7 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.17681423 |
| 8 | Abnormality of glycolipid metabolism (HP:0010969) | 4.17681423 |
| 9 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.98861031 |
| 10 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.98861031 |
| 11 | Abnormal ciliary motility (HP:0012262) | 3.49280151 |
| 12 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.45646462 |
| 13 | Congenital, generalized hypertrichosis (HP:0004540) | 3.36377317 |
| 14 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.29405064 |
| 15 | Osteolytic defects of the hand bones (HP:0009699) | 3.29405064 |
| 16 | Spontaneous hematomas (HP:0007420) | 3.14718247 |
| 17 | Portal hypertension (HP:0001409) | 3.13696164 |
| 18 | Petechiae (HP:0000967) | 3.12354698 |
| 19 | Myocardial infarction (HP:0001658) | 3.08465483 |
| 20 | Polycythemia (HP:0001901) | 3.07696459 |
| 21 | Recurrent bacterial skin infections (HP:0005406) | 2.96377432 |
| 22 | Myositis (HP:0100614) | 2.96015139 |
| 23 | Adactyly (HP:0009776) | 2.95387981 |
| 24 | Esophageal varix (HP:0002040) | 2.92282394 |
| 25 | Abnormality of the hepatic vasculature (HP:0006707) | 2.89990219 |
| 26 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.85310044 |
| 27 | Pulmonary artery stenosis (HP:0004415) | 2.85284854 |
| 28 | Prolonged bleeding time (HP:0003010) | 2.85141963 |
| 29 | Dysostosis multiplex (HP:0000943) | 2.80979031 |
| 30 | Hematochezia (HP:0002573) | 2.71327078 |
| 31 | Thick nail (HP:0001805) | 2.70556203 |
| 32 | Vacuolated lymphocytes (HP:0001922) | 2.66734371 |
| 33 | Eczematoid dermatitis (HP:0000976) | 2.66600249 |
| 34 | Prostate neoplasm (HP:0100787) | 2.64652760 |
| 35 | Hypoglycemic seizures (HP:0002173) | 2.60093897 |
| 36 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.58441858 |
| 37 | Systemic lupus erythematosus (HP:0002725) | 2.56785152 |
| 38 | Poikilocytosis (HP:0004447) | 2.52405961 |
| 39 | Mediastinal lymphadenopathy (HP:0100721) | 2.52277770 |
| 40 | Orchitis (HP:0100796) | 2.45533559 |
| 41 | Optic neuritis (HP:0100653) | 2.40557214 |
| 42 | Retrobulbar optic neuritis (HP:0100654) | 2.40557214 |
| 43 | Colitis (HP:0002583) | 2.39802306 |
| 44 | Aplasia cutis congenita (HP:0001057) | 2.39383877 |
| 45 | Papillary thyroid carcinoma (HP:0002895) | 2.39342981 |
| 46 | Facial diplegia (HP:0001349) | 2.39041290 |
| 47 | Autoimmune thrombocytopenia (HP:0001973) | 2.35137741 |
| 48 | Ankyloglossia (HP:0010296) | 2.31814522 |
| 49 | IgA deficiency (HP:0002720) | 2.30903222 |
| 50 | Loss of speech (HP:0002371) | 2.30314958 |
| 51 | Onycholysis (HP:0001806) | 2.30251845 |
| 52 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.26737399 |
| 53 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.26737399 |
| 54 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.26737399 |
| 55 | Vertebral compression fractures (HP:0002953) | 2.24979116 |
| 56 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.24930872 |
| 57 | Mucopolysacchariduria (HP:0008155) | 2.24930872 |
| 58 | Distal lower limb muscle weakness (HP:0009053) | 2.24630010 |
| 59 | Thrombocytosis (HP:0001894) | 2.23869580 |
| 60 | Lip pit (HP:0100267) | 2.23001503 |
| 61 | Absent hand (HP:0004050) | 2.22868828 |
| 62 | Epistaxis (HP:0000421) | 2.22818955 |
| 63 | Increased IgE level (HP:0003212) | 2.22690531 |
| 64 | Patchy hypopigmentation of hair (HP:0011365) | 2.21605211 |
| 65 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.19361384 |
| 66 | Acanthocytosis (HP:0001927) | 2.17583280 |
| 67 | Abnormality of the common coagulation pathway (HP:0010990) | 2.17052067 |
| 68 | Anhidrosis (HP:0000970) | 2.16671954 |
| 69 | Porencephaly (HP:0002132) | 2.16423986 |
| 70 | Atrial fibrillation (HP:0005110) | 2.15450476 |
| 71 | Impaired platelet aggregation (HP:0003540) | 2.13994353 |
| 72 | Abnormal platelet function (HP:0011869) | 2.13994353 |
| 73 | Fatigue (HP:0012378) | 2.13855837 |
| 74 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.13140514 |
| 75 | Bronchiectasis (HP:0002110) | 2.12916671 |
| 76 | Symptomatic seizures (HP:0011145) | 2.12336067 |
| 77 | White forelock (HP:0002211) | 2.11901294 |
| 78 | Disinhibition (HP:0000734) | 2.11658670 |
| 79 | Osteomyelitis (HP:0002754) | 2.10949651 |
| 80 | Mitral stenosis (HP:0001718) | 2.09740733 |
| 81 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.09150510 |
| 82 | Inflammation of the large intestine (HP:0002037) | 2.08808117 |
| 83 | Neurofibrillary tangles (HP:0002185) | 2.08321606 |
| 84 | Nonprogressive disorder (HP:0003680) | 2.07457612 |
| 85 | Tetraparesis (HP:0002273) | 2.06699211 |
| 86 | Increased serum ferritin (HP:0003281) | 2.05941186 |
| 87 | Abnormality of macrophages (HP:0004311) | 2.04655675 |
| 88 | Increased connective tissue (HP:0009025) | 2.04367044 |
| 89 | Stomatitis (HP:0010280) | 2.04277675 |
| 90 | Hypoglycemic coma (HP:0001325) | 2.03551265 |
| 91 | Abnormality of the frontal sinuses (HP:0002687) | 2.01587164 |
| 92 | Glomerulonephritis (HP:0000099) | 2.01193458 |
| 93 | Exercise-induced muscle cramps (HP:0003710) | 2.00755736 |
| 94 | Amyloidosis (HP:0011034) | 1.99666991 |
| 95 | Cerebral inclusion bodies (HP:0100314) | 1.97350479 |
| 96 | Chronic bronchitis (HP:0004469) | 1.92629259 |
| 97 | Arterial thrombosis (HP:0004420) | 1.92100756 |
| 98 | Axonal loss (HP:0003447) | 1.91800652 |
| 99 | Absent frontal sinuses (HP:0002688) | 1.91486974 |
| 100 | Acanthosis nigricans (HP:0000956) | 1.91297785 |
| 101 | Complement deficiency (HP:0004431) | 1.91244539 |
| 102 | Abnormality of secondary sexual hair (HP:0009888) | 1.89908978 |
| 103 | Abnormality of the axillary hair (HP:0100134) | 1.89908978 |
| 104 | Abnormality of oral frenula (HP:0000190) | 1.89401388 |
| 105 | Interstitial pulmonary disease (HP:0006530) | 1.88657526 |
| 106 | Abnormality of iron homeostasis (HP:0011031) | 1.88606993 |
| 107 | Infertility (HP:0000789) | 1.88359521 |
| 108 | Purpura (HP:0000979) | 1.88246256 |
| 109 | Primary atrial arrhythmia (HP:0001692) | 1.87406404 |
| 110 | Gingivitis (HP:0000230) | 1.87249677 |
| 111 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.86526919 |
| 112 | Cellulitis (HP:0100658) | 1.85609286 |
| 113 | Reticulocytosis (HP:0001923) | 1.84272882 |
| 114 | Dilatation of the ascending aorta (HP:0005111) | 1.84247935 |
| 115 | Deep philtrum (HP:0002002) | 1.83810159 |
| 116 | Long foot (HP:0001833) | 1.82803248 |
| 117 | Hypergonadotropic hypogonadism (HP:0000815) | 1.82061666 |
| 118 | Keratoconjunctivitis sicca (HP:0001097) | 1.81013437 |
| 119 | Autoimmune hemolytic anemia (HP:0001890) | 1.80246873 |
| 120 | Bone pain (HP:0002653) | 1.80199282 |
| 121 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.79606278 |
| 122 | Pulmonary hypertension (HP:0002092) | 1.79448439 |
| 123 | Tetany (HP:0001281) | 1.78584030 |
| 124 | Gastrointestinal inflammation (HP:0004386) | 1.78541118 |
| 125 | Increased mean platelet volume (HP:0011877) | 1.78415836 |
| 126 | Slow saccadic eye movements (HP:0000514) | 1.77570687 |
| 127 | Spondylolisthesis (HP:0003302) | 1.77199548 |
| 128 | Abnormality of complement system (HP:0005339) | 1.76683781 |
| 129 | Chronic otitis media (HP:0000389) | 1.76608109 |
| 130 | Bronchitis (HP:0012387) | 1.76246530 |
| 131 | Paralysis (HP:0003470) | 1.76028331 |
| 132 | Supraventricular tachycardia (HP:0004755) | 1.75705968 |
| 133 | Supraventricular arrhythmia (HP:0005115) | 1.75524754 |
| 134 | Nonimmune hydrops fetalis (HP:0001790) | 1.75485719 |
| 135 | Abnormal platelet volume (HP:0011876) | 1.74698197 |
| 136 | Renal cortical cysts (HP:0000803) | 1.74484451 |
| 137 | Pulmonary infiltrates (HP:0002113) | 1.73288359 |
| 138 | Lower limb hyperreflexia (HP:0002395) | 1.73007018 |
| 139 | Abnormality of the renal cortex (HP:0011035) | 1.73006955 |
| 140 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.72444169 |
| 141 | Increased cerebral lipofuscin (HP:0011813) | 1.72410201 |
| 142 | Abnormality of the periventricular white matter (HP:0002518) | 1.71608352 |
| 143 | Intrahepatic cholestasis (HP:0001406) | 1.71070534 |
| 144 | Vasculitis (HP:0002633) | 1.70909845 |
| 145 | Hemorrhage of the eye (HP:0011885) | 1.70224534 |
| 146 | Relative macrocephaly (HP:0004482) | 1.70119678 |
| 147 | Acute myeloid leukemia (HP:0004808) | 1.69398008 |
| 148 | Wormian bones (HP:0002645) | 1.69365494 |
| 149 | Urticaria (HP:0001025) | 1.69252904 |
| 150 | Ectropion (HP:0000656) | 1.68322595 |
| 151 | Personality changes (HP:0000751) | 1.67843298 |
| 152 | Hypertensive crisis (HP:0100735) | 1.67691850 |
| 153 | Recurrent skin infections (HP:0001581) | 1.66690255 |
| 154 | Microretrognathia (HP:0000308) | 1.66682162 |
| 155 | Menorrhagia (HP:0000132) | 1.66514913 |
| 156 | Weak cry (HP:0001612) | 1.66075799 |
| 157 | Autoamputation (HP:0001218) | 1.66073205 |
| 158 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.65925477 |
| 159 | Global brain atrophy (HP:0002283) | 1.65756506 |
| 160 | Abnormality of the prostate (HP:0008775) | 1.65610740 |
| 161 | Reduced antithrombin III activity (HP:0001976) | 1.65584710 |
| 162 | Recurrent bronchitis (HP:0002837) | 1.65324711 |
| 163 | Metaphyseal dysplasia (HP:0100255) | 1.65307215 |
| 164 | Hypertriglyceridemia (HP:0002155) | 1.64649070 |
| 165 | Progressive neurologic deterioration (HP:0002344) | 1.64035046 |
| 166 | Bruising susceptibility (HP:0000978) | 1.63824106 |
| 167 | Gingival bleeding (HP:0000225) | 1.63508162 |
| 168 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.63464712 |
| 169 | Basal ganglia calcification (HP:0002135) | 1.63370822 |
| 170 | Coarse hair (HP:0002208) | 1.62874736 |
| 171 | Dysmetric saccades (HP:0000641) | 1.62665468 |
| 172 | Cholelithiasis (HP:0001081) | 1.62114651 |
| 173 | Cardiomegaly (HP:0001640) | 1.61386852 |
| 174 | Cardiovascular calcification (HP:0011915) | 1.60402187 |
| 175 | Steatorrhea (HP:0002570) | 1.60273986 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 6.56866156 |
| 2 | BMPR2 | 3.24363615 |
| 3 | INSRR | 3.21342391 |
| 4 | GRK1 | 3.00207083 |
| 5 | PRPF4B | 2.95355767 |
| 6 | KDR | 2.92272665 |
| 7 | NLK | 2.76675689 |
| 8 | TGFBR2 | 2.74669460 |
| 9 | TEC | 2.63785780 |
| 10 | IRAK3 | 2.41455456 |
| 11 | MAP3K12 | 2.22489629 |
| 12 | MAP3K14 | 2.20911349 |
| 13 | AKT3 | 2.08734148 |
| 14 | MAP3K2 | 1.97635789 |
| 15 | PDK2 | 1.95740071 |
| 16 | EIF2AK1 | 1.94358993 |
| 17 | MUSK | 1.93946340 |
| 18 | MYLK | 1.84963840 |
| 19 | MAP4K1 | 1.81676848 |
| 20 | ERN1 | 1.80877983 |
| 21 | SCYL2 | 1.79157110 |
| 22 | ZAK | 1.77643826 |
| 23 | TXK | 1.72020356 |
| 24 | KSR2 | 1.65432251 |
| 25 | TAOK2 | 1.50534588 |
| 26 | IRAK4 | 1.44070453 |
| 27 | IKBKE | 1.43638685 |
| 28 | KIT | 1.40248645 |
| 29 | TRPM7 | 1.38282004 |
| 30 | BLK | 1.30853026 |
| 31 | IKBKB | 1.29913976 |
| 32 | RAF1 | 1.27914533 |
| 33 | MAP3K1 | 1.26854905 |
| 34 | PIM1 | 1.22932975 |
| 35 | MAP3K3 | 1.22369109 |
| 36 | TBK1 | 1.20876921 |
| 37 | JAK2 | 1.18968124 |
| 38 | FRK | 1.18908423 |
| 39 | PDGFRA | 1.18734736 |
| 40 | DDR2 | 1.15325810 |
| 41 | MAPK15 | 1.14906094 |
| 42 | TYK2 | 1.14861250 |
| 43 | ICK | 1.14714195 |
| 44 | PRKG2 | 1.10351646 |
| 45 | CLK1 | 1.07794497 |
| 46 | CHUK | 1.06687840 |
| 47 | NUAK1 | 1.05931971 |
| 48 | BMPR1B | 1.05544474 |
| 49 | PIM2 | 1.04533495 |
| 50 | TGFBR1 | 1.03082715 |
| 51 | PDK3 | 1.02851012 |
| 52 | PDK4 | 1.02851012 |
| 53 | ARAF | 1.02838568 |
| 54 | CDK12 | 1.02323542 |
| 55 | MAPK7 | 1.02238143 |
| 56 | CDK9 | 1.01650038 |
| 57 | MAP2K3 | 0.98569387 |
| 58 | OBSCN | 0.97696919 |
| 59 | ITK | 0.97032985 |
| 60 | RIPK4 | 0.96979378 |
| 61 | PINK1 | 0.94960977 |
| 62 | TAOK1 | 0.93530261 |
| 63 | BMX | 0.92223043 |
| 64 | BTK | 0.91870325 |
| 65 | TRIB3 | 0.90687315 |
| 66 | JAK3 | 0.88585316 |
| 67 | BRAF | 0.87370895 |
| 68 | TAOK3 | 0.87140978 |
| 69 | NME2 | 0.86817124 |
| 70 | NEK6 | 0.86448963 |
| 71 | PTK2B | 0.86403053 |
| 72 | EIF2AK3 | 0.84504012 |
| 73 | PIK3CG | 0.84002088 |
| 74 | CAMK1D | 0.83660618 |
| 75 | MAP3K13 | 0.82255165 |
| 76 | PRKAA2 | 0.81141344 |
| 77 | EEF2K | 0.80942267 |
| 78 | YES1 | 0.80311055 |
| 79 | STK24 | 0.79608810 |
| 80 | KSR1 | 0.78696293 |
| 81 | CAMK1G | 0.76332548 |
| 82 | CSF1R | 0.75730769 |
| 83 | STK10 | 0.75720854 |
| 84 | MATK | 0.75140428 |
| 85 | SGK3 | 0.74440083 |
| 86 | CDK6 | 0.73655449 |
| 87 | JAK1 | 0.72727122 |
| 88 | MAP3K5 | 0.72685420 |
| 89 | MST4 | 0.72405004 |
| 90 | MAP3K8 | 0.72277463 |
| 91 | MAP2K2 | 0.70609510 |
| 92 | GRK7 | 0.69974825 |
| 93 | NEK9 | 0.69172350 |
| 94 | MAPKAPK5 | 0.66855492 |
| 95 | LYN | 0.65882420 |
| 96 | IRAK2 | 0.64333107 |
| 97 | CDC42BPA | 0.64194789 |
| 98 | MST1R | 0.62916533 |
| 99 | IRAK1 | 0.62468637 |
| 100 | MOS | 0.60094091 |
| 101 | PDPK1 | 0.59789429 |
| 102 | PDGFRB | 0.59477981 |
| 103 | IGF1R | 0.59287612 |
| 104 | MAPK12 | 0.58926765 |
| 105 | DMPK | 0.58308086 |
| 106 | PAK4 | 0.58275182 |
| 107 | MAPKAPK3 | 0.58078702 |
| 108 | LCK | 0.57437715 |
| 109 | RET | 0.56884310 |
| 110 | WNK4 | 0.56368756 |
| 111 | ZAP70 | 0.55173146 |
| 112 | CAMKK2 | 0.54565370 |
| 113 | FGFR4 | 0.54386244 |
| 114 | CSK | 0.53404716 |
| 115 | HCK | 0.53109597 |
| 116 | EIF2AK2 | 0.53060177 |
| 117 | FGR | 0.53017104 |
| 118 | ABL1 | 0.52576573 |
| 119 | SYK | 0.52385398 |
| 120 | MAPK11 | 0.51977624 |
| 121 | LATS1 | 0.50916938 |
| 122 | SGK2 | 0.50441501 |
| 123 | WNK1 | 0.50102360 |
| 124 | FER | 0.49676020 |
| 125 | TNIK | 0.48308822 |
| 126 | MTOR | 0.47198727 |
| 127 | FGFR3 | 0.47000525 |
| 128 | DYRK1B | 0.45954898 |
| 129 | LRRK2 | 0.45579537 |
| 130 | MKNK2 | 0.44912941 |
| 131 | TTN | 0.44845884 |
| 132 | PBK | 0.44784627 |
| 133 | MAP2K1 | 0.44189339 |
| 134 | MELK | 0.44171136 |
| 135 | MARK3 | 0.43438314 |
| 136 | MAP3K6 | 0.42940324 |
| 137 | PIK3CA | 0.42084437 |
| 138 | RIPK1 | 0.41986304 |
| 139 | PRKCE | 0.40704035 |
| 140 | EGFR | 0.37204809 |
| 141 | STK3 | 0.36322256 |
| 142 | PRKD2 | 0.34554790 |
| 143 | GSK3A | 0.32991181 |
| 144 | PRKCH | 0.31465862 |
| 145 | PDK1 | 0.31174915 |
| 146 | PRKCQ | 0.29695923 |
| 147 | PRKD1 | 0.29117516 |
| 148 | RPS6KA5 | 0.28673175 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.55609429 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.54266531 |
| 3 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.24860027 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.21776202 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.16090816 |
| 6 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.06214111 |
| 7 | Asthma_Homo sapiens_hsa05310 | 2.05670791 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.05381893 |
| 9 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.99641581 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 1.98871393 |
| 11 | Lysosome_Homo sapiens_hsa04142 | 1.93321796 |
| 12 | ABC transporters_Homo sapiens_hsa02010 | 1.89505306 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.86011616 |
| 14 | Measles_Homo sapiens_hsa05162 | 1.81766110 |
| 15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.78819759 |
| 16 | Malaria_Homo sapiens_hsa05144 | 1.73481983 |
| 17 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.69441037 |
| 18 | * Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.68157697 |
| 19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.66013269 |
| 20 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.64204170 |
| 21 | Pertussis_Homo sapiens_hsa05133 | 1.63287156 |
| 22 | Adherens junction_Homo sapiens_hsa04520 | 1.59822243 |
| 23 | Platelet activation_Homo sapiens_hsa04611 | 1.58150974 |
| 24 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.54788751 |
| 25 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.52283857 |
| 26 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.52041017 |
| 27 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.45279837 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.42718825 |
| 29 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.37381658 |
| 30 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.36786688 |
| 31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.35981091 |
| 32 | Legionellosis_Homo sapiens_hsa05134 | 1.30192726 |
| 33 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.27364384 |
| 34 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.26993757 |
| 35 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.26747868 |
| 36 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.26624053 |
| 37 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.26385325 |
| 38 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.21651045 |
| 39 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.20490390 |
| 40 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.20063684 |
| 41 | Prion diseases_Homo sapiens_hsa05020 | 1.17693745 |
| 42 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.16364630 |
| 43 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.14565692 |
| 44 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.11148042 |
| 45 | Bladder cancer_Homo sapiens_hsa05219 | 1.10150547 |
| 46 | Mineral absorption_Homo sapiens_hsa04978 | 1.06311186 |
| 47 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.05811825 |
| 48 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.05794334 |
| 49 | Influenza A_Homo sapiens_hsa05164 | 1.05554751 |
| 50 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.05317486 |
| 51 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.01115086 |
| 52 | Hepatitis C_Homo sapiens_hsa05160 | 0.98567039 |
| 53 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.98460474 |
| 54 | Focal adhesion_Homo sapiens_hsa04510 | 0.97928151 |
| 55 | Thyroid cancer_Homo sapiens_hsa05216 | 0.97799713 |
| 56 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.97629777 |
| 57 | Salmonella infection_Homo sapiens_hsa05132 | 0.96927691 |
| 58 | Shigellosis_Homo sapiens_hsa05131 | 0.95842612 |
| 59 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.95658816 |
| 60 | Tuberculosis_Homo sapiens_hsa05152 | 0.93493568 |
| 61 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.90535759 |
| 62 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.90366841 |
| 63 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.90093521 |
| 64 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.89627394 |
| 65 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.88828979 |
| 66 | Viral myocarditis_Homo sapiens_hsa05416 | 0.87769616 |
| 67 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.86522165 |
| 68 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.85627604 |
| 69 | Other glycan degradation_Homo sapiens_hsa00511 | 0.85253370 |
| 70 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.84595390 |
| 71 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.84136515 |
| 72 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.83427684 |
| 73 | Prostate cancer_Homo sapiens_hsa05215 | 0.83161223 |
| 74 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.82243664 |
| 75 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.81961489 |
| 76 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.80466448 |
| 77 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.79368574 |
| 78 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.78645277 |
| 79 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.78016703 |
| 80 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.77274351 |
| 81 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.76782125 |
| 82 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.76758413 |
| 83 | Amoebiasis_Homo sapiens_hsa05146 | 0.75895367 |
| 84 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.75023885 |
| 85 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.74886755 |
| 86 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.74293933 |
| 87 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.73997717 |
| 88 | Apoptosis_Homo sapiens_hsa04210 | 0.73337003 |
| 89 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.72595120 |
| 90 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.71995490 |
| 91 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.68577384 |
| 92 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.67841630 |
| 93 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.67362053 |
| 94 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.66933075 |
| 95 | Endometrial cancer_Homo sapiens_hsa05213 | 0.65448882 |
| 96 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.62892655 |
| 97 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.61755835 |
| 98 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.61494928 |
| 99 | Hepatitis B_Homo sapiens_hsa05161 | 0.60564881 |
| 100 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.59225353 |
| 101 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.58736197 |
| 102 | Insulin resistance_Homo sapiens_hsa04931 | 0.58414964 |
| 103 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.58207292 |
| 104 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.57629264 |
| 105 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.57473593 |
| 106 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.56836745 |
| 107 | Endocytosis_Homo sapiens_hsa04144 | 0.56662461 |
| 108 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.56533791 |
| 109 | Glioma_Homo sapiens_hsa05214 | 0.55145808 |
| 110 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.54060347 |
| 111 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.53953149 |
| 112 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.53630321 |
| 113 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.52229513 |
| 114 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.52178194 |
| 115 | Renin secretion_Homo sapiens_hsa04924 | 0.51140998 |
| 116 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50930355 |
| 117 | Pathways in cancer_Homo sapiens_hsa05200 | 0.50625432 |
| 118 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.49554915 |
| 119 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.49157702 |
| 120 | Phagosome_Homo sapiens_hsa04145 | 0.48843951 |
| 121 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.48803941 |
| 122 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.48629911 |
| 123 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.47514492 |
| 124 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.46957111 |
| 125 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.46539509 |
| 126 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.46517030 |
| 127 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.45957151 |
| 128 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.42818831 |
| 129 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.42788918 |
| 130 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.42340371 |
| 131 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.41718344 |
| 132 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.41173467 |
| 133 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.40981290 |
| 134 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.39717427 |
| 135 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.39074106 |

